The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment

BACKGROUND: Metabolomic processes have been identified as being strongly linked to the development of Alzheimer's disease (AD). Thus, lipid metabolites appear to be highly useful as diagnostic substrates for the diagnosis of AD and mild cognitive impairment (MCI) in plasma. METHODS: We analyzed...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Alzheimers Dement (Amst)
Hlavní autoři: Klavins, Kristaps, Koal, Therese, Dallmann, Guido, Marksteiner, Josef, Kemmler, Georg, Humpel, Christian
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2015
Témata:
Blood-Based Biomarkers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4700585/
https://ncbi.nlm.nih.gov/pubmed/26744734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.05.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky